Analyst Ratings for Virpax Pharmaceuticals, Inc. (VRPX)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/9/2024 | Maxim Group | Naz Rahman | Downgrade | Hold (Buy) |
N/A (N/A) |
0.49 (0.67) |
36.73% | Details |
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/9/2024 | Maxim Group | Naz Rahman | Downgrade | Hold (Buy) |
N/A (N/A) |
0.49 (0.67) |
36.73% | Details |